Molecular Characterization of Moraxella Catarrhalis From Pneumonic Children at Pediatric Assiut University Hospital
Mcatarrhalis
1 other identifier
observational
90
0 countries
N/A
Brief Summary
moraxella catarrhalis is responsible for respiratory tract infection in children and adults with streptococcus pneumonia and haemophilus influenza.Moraxella catarrhalis is gram negative diplococci, non-motile and non spore bearing bacteria. Until, 1995 it was considered as a non pathogenic respiratory tract flora.This bacteria is an important pathogen and a common cause of both upper and lower respiratory tract infections, pneumonia, sinusitis and conjunctivitis in infants, children and in elderly patients. In adults, M. catarrhalis also causes chronic obstructive pulmonary disease (COPD) and pneumonia. However, it is associated with a number of respiratory infections affecting both children and adults, including laryngitis, bronchitis and pneumonia .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 20, 2027
April 16, 2024
April 1, 2024
3 years
April 5, 2024
April 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
isolation of moraxella catarrhalis
isolation of organism on muller hinton agar
3 years
Secondary Outcomes (2)
detection of virulence genes of moraxella catarrhalis
3 years
detetion of antibiotic resistance
3years
Eligibility Criteria
children with respiratory tract infection
You may qualify if:
- all children with bacterial pneumonia
You may not qualify if:
- viral pneumonia , tuberculosis and immunocompromised
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008 Nov 27;359(22):2355-65. doi: 10.1056/NEJMra0800353. No abstract available.
PMID: 19038881BACKGROUNDBlakeway LV, Tan A, Peak IRA, Seib KL. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development. Microbiology (Reading). 2017 Oct;163(10):1371-1384. doi: 10.1099/mic.0.000523. Epub 2017 Sep 12.
PMID: 28893369BACKGROUNDBernhard S, Spaniol V, Aebi C. Molecular pathogenesis of infections caused by Moraxella catarrhalis in children. Swiss Med Wkly. 2012 Oct 29;142:w13694. doi: 10.4414/smw.2012.13694. eCollection 2012.
PMID: 23136074BACKGROUND
Biospecimen
sputum samples for DNA extraction and PCR
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- faculty of medicine meical microbiology and immunology
Study Record Dates
First Submitted
April 5, 2024
First Posted
April 10, 2024
Study Start
December 1, 2024
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 20, 2027
Last Updated
April 16, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
ethical consideration